Trial Profile
Effects of Lixisenatide on Gastric Emptying, Glycaemia and 'Postprandial' Blood Pressure in Type 2 Diabetes and Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Apr 2022
Price :
$35
*
At a glance
- Drugs Lixisenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms Lixi
- 22 Apr 2022 Results published in the Diabetes Therapy
- 08 Jan 2020 Status changed from recruiting to completed, according to results presented at the 55th Annual Meeting of the European Association for the Study of Diabetes
- 15 Sep 2017 Primary endpoint (Systolic Blood Pressure compared to placebo) has been met as per the results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes